DELLA PEPA, Carlo

DELLA PEPA, Carlo  

SCIENZA E TECNOLOGIA DEL FARMACO  

Mostra records
Risultati 1 - 20 di 31 (tempo di esecuzione: 0.035 secondi).
Titolo Data di pubblicazione Autore(i) File
A Non-Parametric Population PK/PD Analysis Of Tolcapone To Predict L-Dopa Plasma Concentrations 1998 Costa M; Berno E; Zara GP; Della Pepa C; Canaparo R; Eandi M
Antibiotic dosage individualization through Bayesian inference on PK-PD population data 1996 Eandi M; Costa M; Della Pepa C; Canaparo R; Zara GP
Application of Parzaen-based probabilistic neural networks to predict individual plasma concentration from population data 2003 CASALE F; COSTA M; CANAPARO R; MUNTONI E; DELLA PEPA C; BERNO E; ZARA GP; PASERO E; EANDI M
Application of pharmacoeconomics to the use of antibiotics. 2000 EANDI M ;ZARA GP ;DELLA PEPA C
Betahistine in the treatment of vertiginous syndromes: a meta-analysis 2006 DELLA PEPA C; GUIDETTI G; EANDI M
Biological Effect Evaluation of Glutathione-Responsive Cyclodextrin-Based Nanosponges: 2D and 3D Studies 2020 Argenziano M.; Foglietta F.; Canaparo R.; Spagnolo R.; Della Pepa C.; Caldera F.; Trotta F.; Serpe L.; Cavalli R.
Cannabinoid Delivery Systems for Pain and Inflammation Treatment 2018 Bruni, Natascia; Della Pepa, Carlo; Oliaro-Bosso, Simonetta; Pessione, Enrica; Gastaldi, Daniela; Dosio, Franco
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain 2021 Stella B.; Baratta F.; Della Pepa C.; Arpicco S.; Gastaldi D.; Dosio F.
Determination of disodium clodronate in human plasma and urine using gas-chromatography-nitrogen-phosphorous detection: validation and application in pharmacokinetic study 2004 MUNTONI E; CANAPARO R; DELLA PEPA C; SERPE L; CASALE F; BARBERA S; ROMANO P; ZARA GP; EANDI M
Determination of Ibuprofen in human plasma by high performance liquid chromatography: validation and application in pharmacokinetic study 2000 R. CANAPARO; MUNTONI E; ZARA GP; DELLA PEPA C; BERNO E; COSTA M; EANDI M
HPLC determination of 5-FU and three metabolites in the plasma of cancer patients 2000 Canaparo R; Muntoni E; Serpe L; Della Pepa C; Zara GP; Casale F; Eandi M
Individualization of Ceftriaxone dosage through Bayesian inference on PK/PD population data 1997 Eandi M; Costa M; Della Pepa C; Canaparo R; Zara GP
Influence of creatine supplementation on psychomotor performance 2001 Pradelli L; Della Pepa C; Serpe L; Eandi M
Intracellular accumulation and cytotoxicity of doxorubicin with different pharmaceutical formulations in human cancer cell lines 2006 SERPE L; GUIDO M; CANAPARO R; MUNTONI E; CAVALLI R; PANZANELLI P; DELLA PEPA C; BARGONI A; MAURO A; GASCO MR; EANDI M; ZARA GP
Motilin and erythromycin do not affect the motility of rat duodenum in vivo 1996 Zara GP; Tarantino A; Bonabello A; Rossi C; Della Pepa C; Canaparo R; Eandi M
Nanostructured delivery systems with improved leishmanicidal activity: a critical review 2017 Bruni, Natascia; Stella, Barbara; Giraudo, Leonardo; Della Pepa, Carlo; Gastaldi, Daniela; Dosio, Franco
Pharmacokinetics and tolerability profile of three new formulations of disodium clodronate after single intramuscular injection in healthy volunteers 2001 Della Pepa C; Muntoni E; Serpe L; Casale F; Pradelli L; Romano P; Eandi M
Pharmacokinetics of disodium clodronate after single intravenous or intramuscolar injection in healthy volunteers 2000 Della Pepa C; Muntoni E; Canaparo R; Romano P; Dosio F; Zara GP; Eandi M
Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients 2004 CASALE F; CANAPARO R; SERPE R; MUNTONI E; DELLA PEPA C; COSTA M; MAIRONE L; ZARA GP; FORNARI G; EANDI M
Plasma Erythropoietin levels in patients receiving intensive platinum or non-platinum chemotherapy 2000 R. CANAPARO; CASALE F; MUNTONI E; ZARA GP; DELLA PEPA C; BERNO E; PONS N; FORNARI G; EANDI M